The increased level of serum galectin-3 in IBD patients found in this study is in agreement with an early report showing higher serum galectin-3 level in IBD patients, irrespective of their disease activity, compared with healthy people[22]. This evidence concerns the gene LGALS3 and inflammatory bowel disease.